XAR Vs. DFEN: Defense ETFs Amid The Putin-Trump-Zelenskyy Triangulation
Defense stocks are overvalued with high forward P/Es and a strong war premium, making volatility risk significant, especially for leveraged ETFs like DFEN. DFEN's daily 3x leverage amplifies volatility drag, making it unsuitable for long-term holding. But beware, this does not necessarily mean the end of the bullish phase for the aerospace and defense sector.
Should You Invest in the SPDR S&P Aerospace & Defense ETF (XAR)?
Designed to provide broad exposure to the Industrials - Aerospace & Defense segment of the equity market, the SPDR S&P Aerospace & Defense ETF (XAR) is a passively managed exchange traded fund launched on September 28, 2011.
Is SPDR S&P Aerospace & Defense ETF (XAR) a Strong ETF Right Now?
Designed to provide broad exposure to the Industrials ETFs category of the market, the SPDR S&P Aerospace & Defense ETF (XAR) is a smart beta exchange traded fund launched on 09/28/2011.
Aerospace & Defense ETF (XAR) Hits New 52-Week High
XAR hit a 52-week high as rising global defense budgets and geopolitical tensions fuel sector momentum.
XAR: New Trends In The Aerospace And Defense Industry Drive This ETF
SPDR S&P Aerospace & Defense ETF offers diversified exposure to the U.S. aerospace and defense sector with 40 holdings and no heavy concentration in top positions. With $3.5 billion in assets under management, XAR stands out among peers like ITA, PPA, and MISL for its scale and liquidity. A key advantage of XAR is its competitive management fee of 0.35%, making it a cost-effective choice for sector exposure.
Iran Escalation Could Rally U.S. Defense Stocks -- XAR My Top ETF Choice
US Aerospace & Defense stocks are poised for improved sentiment due to escalating Middle East tensions and direct US involvement in Iran. Recent negative pressures—peace prospects in Ukraine and potential US defense budget cuts—have faded, with a $1 trillion budget proposal boosting the sector. Key beneficiaries include Boeing, Northrop Grumman, RTX, and Lockheed Martin, as their products are central to current military actions.
Should You Invest in the SPDR S&P Aerospace & Defense ETF (XAR)?
If you're interested in broad exposure to the Industrials - Aerospace & Defense segment of the equity market, look no further than the SPDR S&P Aerospace & Defense ETF (XAR), a passively managed exchange traded fund launched on 09/28/2011.
Is SPDR S&P Aerospace & Defense ETF (XAR) a Strong ETF Right Now?
A smart beta exchange traded fund, the SPDR S&P Aerospace & Defense ETF (XAR) debuted on 09/28/2011, and offers broad exposure to the Industrials ETFs category of the market.
XAR: Often The Best Offense Is A Great Defense (And Aerospace) ETF
The SPDR S&P Aerospace & Defense ETF has outperformed the S&P 500 by nearly 20% since July 2023, with a +47.9% return. The defense & aerospace sector is evolving, with private companies and drone warfare driving innovation and competition for government & private contracts. XAR's diversified portfolio, including top holdings like AeroVironment, Axon Enterprise, and Boeing, offers strong growth potential and capital appreciation.
Should You Invest in the SPDR S&P Aerospace & Defense ETF (XAR)?
The SPDR S&P Aerospace & Defense ETF (XAR) was launched on 09/28/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Industrials - Aerospace & Defense segment of the equity market.
Is SPDR S&P Aerospace & Defense ETF (XAR) a Strong ETF Right Now?
The SPDR S&P Aerospace & Defense ETF (XAR) made its debut on 09/28/2011, and is a smart beta exchange traded fund that provides broad exposure to the Industrials ETFs category of the market.
XAR ETF May Have Returned To An Attractive Valuation: A Focus On The Aerospace And Defense Industry
XAR is an ETF holding 35 stocks, tracking the performance of the S&P® Aerospace & Defense Select Industry® Index, with an expense ratio of 0.35%. Since January, the ETF's price has declined by nearly 10%, leading to a mean reversion of the P/E ratio. State Street's 3-5 year EPS growth estimate remains at 11%. The forward P/E is at 25, in line with the 10-year average, making XAR's price, in my view, fair value.
